The Glassware Core and its 24 staff members employ over 100 pieces of equipment, throughout theRockefeller, Schwartz and Zuckerman Research Centers, to deliver more than 5,000 pieces of cleaned andsterilized labware to more than 110 investigators and their staff. Daily routines include decontamination andcollection of soiled labware; hand-scrubbing and visual inspection of each piece before further processing incommercial glasswashers; sorting, wrapping, and/or plugging followed by processing in high-temperatureovens and steam autoclaves before return to the laboratories. Specialized procedures also provide for acidwashingand RNase-free preparations.All processing follows standardized operating procedures specially adapted to meet the needs of each user,and is ascertained to meet the minimum standard of 'visually clean' or less than 4 ug/ml of debris, followingthe criteria for acceptance of LeBlanc and the FDA on the validation of cleaning processes. Over 90% of allwork is restocked in each laboratory within an 8-hour time frame, providing cost and space savings to thelaboratories. This core also provides dry ice stores throughout the research environment, assists with themonitoring of disposal of biohazardous waste and broken glass from laboratories, as well as provides for thedecontamination of radioactive and other forms of biohazardous waste. To minimize costs to thelaboratories, only 'hands-on' time is charged for all services.Changes are anticipated in operating procedures to allow increased standardization in washing with the useof acid and alkaline detergents in the glasswashing machines, further reducing the 'hands-on' time chargedto users. When demand dictates, services will be expanded to include standardized cleaning of specializedlaboratory equipment, such as cell and tissue incubators or freezers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA008748-43
Application #
7671804
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-07-31
Project End
2012-12-31
Budget Start
2008-07-31
Budget End
2008-12-31
Support Year
43
Fiscal Year
2008
Total Cost
$545,444
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Moo, Tracy-Ann; Edelweiss, Marcia; Hajiyeva, Sabina et al. (2018) Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection? Ann Surg Oncol 25:1488-1494
Kinsley, Karen; Pritchett, Wendy (2018) Liposomal Irinotecan: Nursing Considerations in an Outpatient Cancer Center Clin J Oncol Nurs 22:221-224
Vargas, Hebert Alberto; Kramer, Gem M; Scott, Andrew M et al. (2018) Reproducibility and Repeatability of Semiquantitative 18F-Fluorodihydrotestosterone Uptake Metrics in Castration-Resistant Prostate Cancer Metastases: A Prospective Multicenter Study. J Nucl Med 59:1516-1523
Ho, A L (2018) Developing androgen receptor targeting for salivary gland cancers. Ann Oncol 29:792-794
Gupta, Piyush; Migliacci, Jocelyn C; Hay, Ashley et al. (2018) Validation and assessment of discordance of the 8th edition AJCC (American Joint Committee on Cancer) clinical and pathologic staging systems in patients with p16+ oropharyngeal cancer treated with surgery and adjuvant radiation at a single institution. Oral Oncol 83:140-146
Aras, Omer; Pearce, Gillian; Watkins, Adam J et al. (2018) An in-vivo pilot study into the effects of FDG-mNP in cancer in mice. PLoS One 13:e0202482
Chou, Chun; Li, Ming O (2018) Tissue-Resident Lymphocytes Across Innate and Adaptive Lineages. Front Immunol 9:2104
Quezada-Diaz, Felipe; Jimenez-Rodriguez, Rosa M; Pappou, Emmanouil P et al. (2018) Effect of Neoadjuvant Systemic Chemotherapy With or Without Chemoradiation on Bowel Function in Rectal Cancer Patients Treated With Total Mesorectal Excision. J Gastrointest Surg :
Schleicher, Stephen M; Bach, Peter B; Matsoukas, Konstantina et al. (2018) Medication overuse in oncology: current trends and future implications for patients and society. Lancet Oncol 19:e200-e208
Moore, Amanda R; Ran, Leili; Guan, Youxin et al. (2018) GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma. Cell Rep 22:2455-2468

Showing the most recent 10 out of 8799 publications